This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Business Wire
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.

Global Dermal Filler Medical Devices Pipeline Assessment 2019: Products Under Development, Companies & Products, and Recent Developments - ResearchAndMarkets.com

February 25, 2019

DUBLIN--(BUSINESS WIRE)--Feb 25, 2019--The “Dermal Filler - Medical Devices Pipeline Assessment, 2019” report has been added to ResearchAndMarkets.com’s offering.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Dermal Filler pipeline products.


Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Dermal Filler Overview

3 Products under Development

3.1 Dermal Filler - Pipeline Products by Stage of Development

3.2 Dermal Filler - Pipeline Products by Territory

3.3 Dermal Filler - Pipeline Products by Regulatory Path

3.4 Dermal Filler - Pipeline Products by Estimated Approval Date

3.5 Dermal Filler - Ongoing Clinical Trials

4 Dermal Filler - Pipeline Products under Development by Companies

4.1 Dermal Filler Companies - Pipeline Products by Stage of Development

4.2 Dermal Filler - Pipeline Products by Stage of Development

5 Dermal Filler Companies and Product Overview

5.1 Aeon Astron Corporation Company Overview

5.2 Allergan Plc Company Overview

5.3 Almirall Ltd Company Overview

5.4 Bioxis Pharmaceuticals Company Overview

5.5 BMG Pharma srl Company Overview

5.6 Bmi Korea Co Ltd Company Overview

5.7 Celltrix AB Company Overview

5.8 CollPlant Holdings Ltd Company Overview

5.9 EternoGen Aesthetics LLC Company Overview

5.10 Genzyme Corp Company Overview

5.11 Innovia LLC Company Overview

5.12 Juvenis Ltd Company Overview

5.13 Khorionyx SA Company Overview

5.14 Medy-Tox Inc Company Overview

5.15 Mesoestetic Pharma Group SL Company Overview

5.16 Moma Therapeutics, Inc. Company Overview

5.17 N8 Medical Inc Company Overview

5.18 Oligo Medic Inc Company Overview

5.19 PB&B SA Company Overview

5.20 PetVivo Holdings Inc Company Overview

5.21 Regenscientific Company Overview

5.22 Samyang Biopharmaceuticals Corp Company Overview

5.23 Sebana Medical Ltd Company Overview

5.24 Sekisui Medical Co Ltd Company Overview

5.25 Shanghai Haohai Biological Technology Co Ltd Company Overview

5.26 Shin Poong PharmCo Ltd Company Overview

5.27 Sinclair Pharma PLC Company Overview

5.28 Sofregen Medical Inc Company Overview

5.29 TEI Biosciences Inc Company Overview

5.30 University of California Santa Barbara Company Overview

6 Dermal Filler- Recent Developments

6.1 Jul 19, 2018: Suneva Medical promotes Patricia Altavilla to chief operating officer

6.2 Jul 05, 2018: Sinclair Pharma: Trading Update for the 6 months to 30 June 2018

6.3 Jun 04, 2018: SWAG Penis Enhancement Procedure Developed by Top Plastic Surgeon Achieving Optimal Results

6.4 May 21, 2018: Nestle Skin Health Announces the FDA Approval of Restylane Lyft for Hands, the First and Only Hyaluronic Acid (HA) Dermal Filler for Use in the Back of Hands

6.5 May 15, 2018: BTG: Final Results For year ended 31 March 2018

6.6 May 09, 2018: FibroGen Reports First Quarter 2018 Financial Results

6.7 May 08, 2018: Smith & Nephew: Change of Directorate

6.8 May 08, 2018: CollPlant Files U.S. Patent Application for Next Generation Dermal Filler

6.9 May 03, 2018: Smith & Nephew First Quarter 2018 Trading Report

6.10 May 02, 2018: Anika Reports First Quarter 2018 Financial Results

6.11 Apr 30, 2018: Sinclair Pharma: Preliminary results for 12 months ended 31 December 2017

6.12 Apr 30, 2018: Sinclair secures 23 million debt facility

6.13 Apr 09, 2018: Merz Aesthetics Launches New Belotero Lips Dermal Filler Products

6.14 Apr 04, 2018: Namal Nawana appointed Chief Executive Officer of Smith & Nephew

6.15 Mar 20, 2018: Governor Abbott Announces Smith & Nephew Adding New Jobs In Fort Worth

6.16 Mar 05, 2018: Anika Therapeutics Names Joseph Darling As CEO And Director

6.17 Mar 01, 2018: Smith & Nephew: Change in Directorate

6.18 Feb 27, 2018: FibroGen Announces Fourth Quarter and Full Year 2017 Financial Results

6.19 Feb 21, 2018: Anika Announces Fourth Quarter and Full Year 2017 Financial Results

6.20 Feb 16, 2018: Merz North America to Highlight Treatments at American Academy of Dermatology Annual Meeting

6.21 Feb 08, 2018: Smith & Nephew Fourth Quarter Trading and Full Year 2017 Results

6.22 Jan 31, 2018: Smith & Nephew Appoints Roland Diggelmann As Non-Executive Director

6.23 Jan 31, 2018: Appointment of Roland Diggelmann as Non-Executive Director

6.24 Jan 16, 2018: Galderma Introduces Restylane Skinboosters

6.25 Jan 16, 2018: Sinclair Pharma: Ellanse Approved for Brazil

7 Appendix

For more information about this report visit https://www.researchandmarkets.com/research/gzqq66/global_dermal?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190225005535/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Medical Devices



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 02/25/2019 07:58 AM/DISC: 02/25/2019 07:58 AM